| 21/094 |
Treatment of Clotting Disorders |
| 21/093 |
Respiratory Conditions |
| 21/092 |
Delayed Transfer of Care and Waiting Times |
| 21/087 |
Parking Management Solutions and Electric Vehicle |
| 21/086 |
Stillbirths |
| 21/084 |
Decarbonisation in Healthcare |
| 21/082 |
Blood Glucose and Ketone Monitoring |
| 21/069 |
Local Guidelines for the Treatment of Axial Spondyloarthritis, Ankylosing Spondylitis and Rheumatoid Arthritis |
| 21/063 |
Cancer Patients |
| 21/062 |
Mobile Telephony Contract Details |
| 21/053 |
Treatment of Neurology Patients |
| 21/052 |
Pagers |
| 21/050 |
Fatigue and Facilities Charter |
| 21/049 |
Contracts with Arconic and Kingspan |
| 21/048 |
Covid19 Deaths |
| 21/046 |
Fax and Operating Systems |
| 21/044 |
Biologic and Biosimilar Products within Rheumatology |
| 21/042 |
Rota Supplier |
| 21/041 |
Video Consultation |
| 21/040 |
UV Disinfection Technology To Prevent HCAI |
